| PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with … E Whittaker, A Bamford, J Kenny, M Kaforou, CE Jones, P Shah, ... JAMA 324 (3), 259-269, 2020 | 361 | 2020 |
| Formation of highly stable dispersions of silane-functionalized reduced graphene oxide S Hou, S Su, ML Kasner, P Shah, K Patel, CJ Madarang Chemical Physics Letters 501 (1-3), 68-74, 2010 | 256 | 2010 |
| Brook's clinical pediatric endocrinology CGD Brook, P Clayton, R Brown John Wiley & Sons, 2009 | 237 | 2009 |
| Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia S Senniappan, S Alexandrescu, N Tatevian, P Shah, V Arya, S Flanagan, ... New England Journal of Medicine 370 (12), 1131-1137, 2014 | 143 | 2014 |
| Therapies and outcomes of congenital hyperinsulinism‐induced hypoglycaemia I Banerjee, M Salomon‐Estebanez, P Shah, J Nicholson, KE Cosgrove, ... Diabetic Medicine 36 (1), 9-21, 2019 | 117 | 2019 |
| Hyperinsulinaemic hypoglycaemia in children and adults P Shah, SA Rahman, H Demirbilek, M Güemes, K Hussain The Lancet Diabetes & Endocrinology 5 (9), 729-742, 2017 | 104 | 2017 |
| The diagnosis and management of hyperinsulinaemic hypoglycaemia K Roženková, M Güemes, P Shah, K Hussain Journal of clinical research in pediatric endocrinology 7 (2), 86, 2015 | 97 | 2015 |
| Hyperinsulinemic hypoglycemia in children and adolescents: recent advances in understanding of pathophysiology and management M Gϋemes, SA Rahman, RR Kapoor, S Flanagan, JAL Houghton, S Misra, ... Reviews in Endocrine and Metabolic Disorders 21, 577-597, 2020 | 76 | 2020 |
| PIMS-TS Study Group and EUCLIDS and PERFORM Consortia E Whittaker, A Bamford, J Kenny, M Kaforou, CE Jones, P Shah, ... Clinical characteristics of 58, 0 | 66 | |
| Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy H Demirbilek, P Shah, VB Arya, L Hinchey, SE Flanagan, S Ellard, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), 3660-3667, 2014 | 64 | 2014 |
| Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals KL Yap, AEK Johnson, D Fischer, P Kandikatla, J Deml, V Nelakuditi, ... Genetics in Medicine 21 (1), 233-242, 2019 | 57 | 2019 |
| Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations VB Arya, M Guemes, A Nessa, S Alam, P Shah, C Gilbert, S Senniappan, ... European journal of endocrinology 171 (6), 685-695, 2014 | 54 | 2014 |
| Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation LC Gregory, CB Ferreira, SK Young-Baird, HJ Williams, M Harakalova, ... EBioMedicine 42, 470-480, 2019 | 41 | 2019 |
| Persistent hyperinsulinaemic hypoglycaemia in infancy P Shah, H Demirbilek, K Hussain Seminars in Pediatric Surgery 23 (2), 76-82, 2014 | 40 | 2014 |
| Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene M Güemes, P Shah, S Silvera, K Morgan, C Gilbert, L Hinchey, K Hussain The Journal of Clinical Endocrinology & Metabolism 102 (3), 822-830, 2017 | 37 | 2017 |
| Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389 D Yau, TW Laver, A Dastamani, S Senniappan, JAL Houghton, G Shaikh, ... PLoS One 15 (2), e0228417, 2020 | 36 | 2020 |
| Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and … S Senniappan, M Hughes, P Shah, V Shah, JP Kaski, P Brogan, ... Journal of Pediatric Endocrinology and Metabolism 26 (9-10), 877-882, 2013 | 36 | 2013 |
| Genetic analysis of pediatric primary adrenal insufficiency of unknown etiology: 25 years’ experience in the UK F Buonocore, A Maharaj, Y Qamar, K Koehler, JP Suntharalingham, ... Journal of the Endocrine Society 5 (8), bvab086, 2021 | 35 | 2021 |
| Diazoxide‐induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom SC Chen, A Dastamani, D Pintus, D Yau, S Aftab, L Bath, C Swinburne, ... Clinical Endocrinology 91 (6), 770-775, 2019 | 35 | 2019 |
| Use of long-acting somatostatin analogue (lanreotide) in an adolescent with diazoxide-responsive congenital hyperinsulinism and its psychological impact P Shah, SA Rahman, S McElroy, C Gilbert, K Morgan, L Hinchey, ... Hormone Research in Paediatrics 84 (5), 355-360, 2015 | 34 | 2015 |
Sarah FlanaganProfessor in Genomic Medicine, Wellcome Trust Senior Research FellowVerified email at exeter.ac.uk
